FDA Mirati Therapeutics Receives Untitled Letter from OPDP for Overstating… Thomas Sullivan Oct 14, 2024 0 The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter…
